Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

The LRRK2 gene is mutated in a Chinese autosomal-dominant Parkinson's disease family.

Guo R, Hu X, Chen Q, Zhang Y, Zhang Y, Sun Y, Hu G.

Genet Test Mol Biomarkers. 2013 Feb;17(2):131-4. doi: 10.1089/gtmb.2012.0294. Epub 2012 Dec 26.

PMID:
23268655
[PubMed - indexed for MEDLINE]
2.

A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's disease.

Wang L, Guo JF, Nie LL, Xu Q, Zuo X, Sun QY, Yan XX, Tang BS.

Neurosci Lett. 2010 Jan 14;468(3):198-201. doi: 10.1016/j.neulet.2009.10.080. Epub 2009 Oct 29.

PMID:
19879329
[PubMed - indexed for MEDLINE]
3.

Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families.

Ohta E, Hasegawa K, Gasser T, Obata F.

Neurosci Lett. 2007 Apr 24;417(1):21-3. Epub 2007 Mar 16.

PMID:
17395370
[PubMed - indexed for MEDLINE]
4.

Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.

Yescas P, López M, Monroy N, Boll MC, Rodríguez-Violante M, Rodríguez U, Ochoa A, Alonso ME.

Neurosci Lett. 2010 Nov 19;485(2):79-82. doi: 10.1016/j.neulet.2010.08.029. Epub 2010 Aug 18.

PMID:
20727385
[PubMed - indexed for MEDLINE]
5.

Screening for LRRK2 mutations in patients with Parkinson's disease in Russia: identification of a novel LRRK2 variant.

Pchelina SN, Yakimovskii AF, Emelyanov AK, Ivanova ON, Schwarzman AL, Singleton AB.

Eur J Neurol. 2008 Jul;15(7):692-6. doi: 10.1111/j.1468-1331.2008.02149.x. Epub 2008 Apr 24.

PMID:
18435766
[PubMed - indexed for MEDLINE]
6.

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.

Farrer MJ, Stone JT, Lin CH, Dächsel JC, Hulihan MM, Haugarvoll K, Ross OA, Wu RM.

Parkinsonism Relat Disord. 2007 Mar;13(2):89-92. Epub 2007 Jan 10.

PMID:
17222580
[PubMed - indexed for MEDLINE]
7.

Comprehensive mutational analysis of LRRK2 reveals variants supporting association with autosomal dominant Parkinson's disease.

Seki N, Takahashi Y, Tomiyama H, Rogaeva E, Murayama S, Mizuno Y, Hattori N, Marras C, Lang AE, George-Hyslop PS, Goto J, Tsuji S.

J Hum Genet. 2011 Sep;56(9):671-5. doi: 10.1038/jhg.2011.79. Epub 2011 Jul 28.

PMID:
21796139
[PubMed - indexed for MEDLINE]
8.

Correlation between LRRK2 gene G2385R polymorphisms and Parkinson's disease.

Yan H, Ma Q, Yang X, Wang Y, Yao Y, Li H.

Mol Med Rep. 2012 Oct;6(4):879-83. doi: 10.3892/mmr.2012.1008. Epub 2012 Jul 26.

PMID:
22842796
[PubMed - indexed for MEDLINE]
9.

LRRK2 and Parkinson's disease in Norway.

Toft M, Haugarvoll K, Ross OA, Farrer MJ, Aasly JO.

Acta Neurol Scand Suppl. 2007;187:72-5.

PMID:
17419834
[PubMed - indexed for MEDLINE]
10.

LRRK2 gene in Parkinson disease: mutation analysis and case control association study.

Paisán-Ruíz C, Lang AE, Kawarai T, Sato C, Salehi-Rad S, Fisman GK, Al-Khairallah T, St George-Hyslop P, Singleton A, Rogaeva E.

Neurology. 2005 Sep 13;65(5):696-700.

PMID:
16157901
[PubMed - indexed for MEDLINE]
11.

LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.

An XK, Peng R, Li T, Burgunder JM, Wu Y, Chen WJ, Zhang JH, Wang YC, Xu YM, Gou YR, Yuan GG, Zhang ZJ.

Eur J Neurol. 2008 Mar;15(3):301-5. doi: 10.1111/j.1468-1331.2007.02052.x. Epub 2008 Jan 14.

PMID:
18201193
[PubMed - indexed for MEDLINE]
12.

LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China.

Fu X, Zheng Y, Hong H, He Y, Zhou S, Guo C, Liu Y, Xian W, Zeng J, Li J, Liu Z, Chen L, Pei Z.

Parkinsonism Relat Disord. 2013 Mar;19(3):397-8. doi: 10.1016/j.parkreldis.2012.08.007. Epub 2012 Sep 13. No abstract available.

PMID:
22981185
[PubMed - indexed for MEDLINE]
13.

A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.

Illarioshkin SN, Shadrina MI, Slominsky PA, Bespalova EV, Zagorovskaya TB, Bagyeva GKh, Markova ED, Limborska SA, Ivanova-Smolenskaya IA.

Eur J Neurol. 2007 Apr;14(4):413-7.

PMID:
17388990
[PubMed - indexed for MEDLINE]
14.

LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.

Gaig C, Ezquerra M, Marti MJ, Muñoz E, Valldeoriola F, Tolosa E.

Arch Neurol. 2006 Mar;63(3):377-82.

PMID:
16533964
[PubMed - indexed for MEDLINE]
15.

LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.

Zabetian CP, Yamamoto M, Lopez AN, Ujike H, Mata IF, Izumi Y, Kaji R, Maruyama H, Morino H, Oda M, Hutter CM, Edwards KL, Schellenberg GD, Tsuang DW, Yearout D, Larson EB, Kawakami H.

Mov Disord. 2009 May 15;24(7):1034-41. doi: 10.1002/mds.22514.

PMID:
19343804
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

P268S in NOD2 associates with susceptibility to Parkinson's disease in Chinese population.

Ma Q, An X, Li Z, Zhang H, Huang W, Cai L, Hu P, Lin Q, Tzeng CM.

Behav Brain Funct. 2013 May 7;9:19. doi: 10.1186/1744-9081-9-19.

PMID:
23651603
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.

Yu L, Hu F, Zou X, Jiang Y, Liu Y, He X, Xi J, Liu L, Liu Z, He L, Xu Y.

Brain Res. 2009 Nov 3;1296:113-6. doi: 10.1016/j.brainres.2009.08.047. Epub 2009 Aug 20.

PMID:
19699188
[PubMed - indexed for MEDLINE]
18.

LRRK2 mutation in familial Parkinson's disease in a Taiwanese population: clinical, PET, and functional studies.

Lin CH, Tzen KY, Yu CY, Tai CH, Farrer MJ, Wu RM.

J Biomed Sci. 2008 Sep;15(5):661-7. doi: 10.1007/s11373-008-9260-0. Epub 2008 Jun 4.

PMID:
18523869
[PubMed - indexed for MEDLINE]
19.

Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.

Perez-Pastene C, Cobb SA, Díaz-Grez F, Hulihan MM, Miranda M, Venegas P, Godoy OT, Kachergus JM, Ross OA, Layson L, Farrer MJ, Segura-Aguilar J.

Neurosci Lett. 2007 Jul 18;422(3):193-7. Epub 2007 Jun 17.

PMID:
17614198
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A Korean Parkinson's disease family with the LRRK2 p.Tyr1699Cys mutation showing clinical heterogeneity.

Kim JS, Cho JW, Shin H, Lee WY, Ki CS, Cho AR, Kim HT.

Mov Disord. 2012 Feb;27(2):320-4. doi: 10.1002/mds.24033. Epub 2011 Dec 9.

PMID:
22162019
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk